Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Özlem Türeci
Age : 53
Country of residence : Unknown
Linked companies : BioNTech SE

Biography of Özlem Türeci 
Özlem Türeci founded BioNTech SE and Ganymed Pharmaceuticals AG. Currently, she holds the position of Chairman for Ci3 Management UG, President at Association For Cancer Immunotherapy and Chief Medical Officer for BioNTech SE. In the past she occupied the position of Chief Executive & Medical Officer at Ganymed Pharmaceuticals AG. Dr. Türeci received an undergraduate degree from Universität des Saarlandes.


Current positions of Özlem Türeci 
Özlem Türeci : Personal Network 
Most Read News 
07/15JAMIE DIMON : Analysis-JPMorgan hoards cash as Dimon expects rates to rise
RE
07/13RICHARD BRANSON : Virgin Galactic acknowledges Branson's pre-launch bike ride never happened
RE
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
RE
07/13ELON MUSK : Musk defends timing of Tesla's $2.6 billion deal for SolarCity
RE
07/26JEFF BEZOS : Bezos-backed plant food firm NotCo joins unicorn club after latest funding
RE
07/26MICHAEL KLEIN : EV maker Lucid rises in Nasdaq debut after merger with Klein-backed SPAC
RE
07/27RAJESH KUMAR : GE warns of inflationary pressure after lifting cash flow estimate
RE
07/26JEFF BEZOS : Bezos offers NASA $2 billion in exchange for moon mission contract
RE
07/27IAN READ : Exclusive-Rivian ready to invest $5 billion in second U.S. assembly plant -document
RE
07/22RYAN COHEN : Flush from Reddit rally, GameStop plots store revival
RE
More news


© 2021 People and Ownership :   
Özlem Türeci : Connections 


Latest news about Özlem Türeci 
07/23PRESS RELEASE : Fighting Infectious Diseases on the African Continent
DJ
06/18PRESS RELEASE : BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma
DJ
04/27PRESS RELEASE : MIG AG records 2020 as the most successful year in its company history and aims at further growth
DJ
02/18PRESS RELEASE : Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
DJ
2020PRESS RELEASE : Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine
DJ
2020BIONTECH : How a Couple's Quest to Cure Cancer Led to the West's First Covid-19 Vaccine
DJ
2020Moderna and Pfizer Are Reinventing Vaccines, Starting With Covid
DJ
More news